Flecainide Tablets
developed to address cardiac rhythm irregularities, to mitigate potential complications.
Strengths: 100mg
Where to Check Availability
Medicine details
- Alternative names
Tambocor
- Therapeutic class
Antiarrhythmic Agent
- Pharmacological class
Class Ic Antiarrhythmic
- Contraindications
heart failure; myocardial infarction; second or third-degree heart block
- Precautions and warnings
requires cardiac monitoring during initiation; may impair driving ability
- Minor side effects
dizziness; visual disturbances; fatigue
- Moderate side effects
bradycardia; palpitations
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Meda Pharmaceuticals
- Onset Time
1–3 hours
- Duration
12 hours
- Storage instructions
Store at room temperature protected from light.
- Drug interactions
beta-blockers; digoxin; amiodarone
- Age restrictions
Consult specialist for paediatric dosing.
Serious side effects
proarrhythmia — requires immediate medical attention; heart block — requires immediate medical attention
Patient summary
developed to address cardiac rhythm irregularities, to mitigate potential complications.
Mechanism of action
Flecainide is a potent sodium channel blocker which slows conduction in the heart, specifically in the atria and His-Purkinje system, thereby stabilizing the cardiac rhythm.
Pregnancy and breastfeeding
Pregnancy: Only use if strictly necessary. Breastfeeding: Excreted in breast milk; consult physician.
Flecainide Tablets
developed to address cardiac rhythm irregularities, to mitigate potential complications.
Editorial Notes
- Active ingredient(s): Flecainide
- Listed indication(s): Atrial Fibrillation, Paroxysmal Supraventricular Tachycardia, Ventricular Arrhythmias
Available option
- 60 tablets - 100 mg1269-100-mg-15144